Glutathione in the Nervous System as a Potential Therapeutic Target to Control the Development and Progression of Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a rare neurological disorder that affects the motor neurons responsible for regulating muscle movement. However, the molecular pathogenic mechanisms of ALS remain poorly understood. A deficiency in the antioxidant tripeptide glutathione (GSH) in the nervous sys...
Main Author: | Kiyoung Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/7/1011 |
Similar Items
-
Amyotrophic Lateral Sclerosis
Published: (2021) -
Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies
by: Pavlína Hemerková, et al.
Published: (2021-03-01) -
The TGF-β System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis
by: Sebastian Peters, et al.
Published: (2017-12-01) -
A review of therapeutics targeting excitotoxicity in amyotrophic lateral sclerosis
by: Chang, Joshua Sua
Published: (2019) -
Progress in clinical diagnosis of amyotrophic lateral sclerosis
by: Qiong YANG, et al.
Published: (2012-06-01)